TD Cowen analyst Charles Rhyee raised the firm’s price target on McKesson (MCK) to $1,000 from $864 and keeps a Buy rating on the shares. The firm said they reported F2Q26 adj. EPS of $9.86 vs cons of $9.03, driven by strength in NA Pharma and benefiting from some 1x items.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK: